NCT06711601 Ultrasound Evaluation of Two Anatomic Landmarks in Spinal Anesthesia for Cesarean Section: the Posterior Superior Iliac Spine VS Iliac Crest
| NCT ID | NCT06711601 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Third Affiliated Hospital of Guangzhou Medical University |
| Condition | Spinal Anesthesia |
| Study Type | OBSERVATIONAL |
| Enrollment | 660 participants |
| Start Date | 2024-10-10 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 660 participants in total. It began in 2024-10-10 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Intercristal line as palpation landmarks to identifying the vertebral level is frequently inaccurate.To find more safe and reliable body surface markers and convenient methods to be solved in clinical work.The investigators performed a two-stage study to evaluated the accuracy of intercristal line and the The Posterior Superior Iliac Spine (PSIS) line to identify the lumbar interspinous spaces for spinal anesthesia using ultrasonography in pregnant woman which will provide a second option.
Eligibility Criteria
Inclusion Criteria: * After obtaining written informed consents,pregnant women at 37-42 weeks of gestation Exclusion Criteria: * BMI ≥ 40 kg/m² (to minimize palpation variability), History of lumbar surgery/deformity (scoliosis, spondylolisthesis or osteoporotic vertebral collapse), Inability to maintain the flexed lateral decubitus position, Participant withdrawal, Unforeseen anatomical anomalies discovered during screening.
Contact & Investigator
Souping Wang, PhD
STUDY DIRECTOR
The Third Affiliated Hospital of Guangzhou Medical University
Frequently Asked Questions
Who can join the NCT06711601 clinical trial?
This trial is open to female participants only, studying Spinal Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06711601 currently recruiting?
Yes, NCT06711601 is actively recruiting participants. Contact the research team at zhangcobra@126.com for enrollment information.
Where is the NCT06711601 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06711601 clinical trial?
NCT06711601 is sponsored by The Third Affiliated Hospital of Guangzhou Medical University. The principal investigator is Souping Wang, PhD at The Third Affiliated Hospital of Guangzhou Medical University. The trial plans to enroll 660 participants.